The 2nd COHEM Congress aims to circulate up to date information and to provide a unique opportunity for world leaders in the field to debate the most vital and contentious issues in benign and malignant Hematology. This thought-provoking academic dialogue will raise the most challenging current clinical and technological questions.
By allocating substantial time for discussions following each debate, audience members are encouraged to take a participating role in this influential academic dialogue. These exciting debates will highlight the key issues raised in 2011 and 2012 and provide clinicians with state-of-the-art recommendations regarding patient care.
We invite you to participate in the 2nd COHEM Congress and to take an active role in this innovative and interactive experience.